Reslizumab, sold under the brand names Cinqair and Cinqaero, is a humanized monoclonal antibody against human interleukin-5 (IL-5). Reslizumab binds specifically...
13 KB (1,383 words) - 07:59, 1 July 2024
alleviate symptoms. Some examples of these drugs include mepolizumab, reslizumab, and benralizumab. Although eosinopenia has long been recognized as a...
14 KB (1,549 words) - 14:59, 25 October 2024
(INN) rescinnamine (INN) Rescriptor Rescula Resectisol reserpine (INN) reslizumab (INN, USAN) resmetirom (INN) resminostat (INN) resocortol (INN) resorantel...
6 KB (338 words) - 05:05, 20 November 2024
are rapidly reduced monoclonal antibody therapy – e.g., mepolizumab or reslizumab against IL-5, prevents eosinophilopoiesis, or benralizumab against IL-5...
29 KB (3,166 words) - 00:19, 9 September 2024
Altrakincept Pascolizumab IL-5-specific blockers: Benralizumab Mepolizumab Reslizumab IL-13-specific blockers: Lebrikizumab Tralokinumab Dual IL-4 and IL-13...
5 KB (560 words) - 00:25, 17 July 2024
interleukin-5 (IL-5) or its receptor (IL-5R), including mepolizumab, reslizumab or benralizumab, in addition to standard care in severe asthma is effective...
169 KB (18,176 words) - 19:21, 20 November 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
23 KB (1,813 words) - 18:30, 5 November 2024
that aid in asthma symptomatic control include omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab and tezepelumab. Omalizumab binds to free human...
27 KB (2,763 words) - 15:14, 19 November 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
26 KB (3,273 words) - 08:48, 14 October 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
17 KB (1,245 words) - 14:04, 2 September 2024
Fontolizumab Inebilizumab Maslimomab Morolimumab Ofatumumab Pexelizumab Reslizumab Rovelizumab Siplizumab Talizumab Telimomab aritox Teprotumumab Vapaliximab...
7 KB (299 words) - 13:45, 27 April 2024
COVID-19 Relatlimab mab human LAG3 melanoma Remtolumab mab human IL-17A, TNF Reslizumab Cinqair mab humanized IL-5 Y inflammations of the airways, skin and gastrointestinal...
137 KB (4,083 words) - 21:25, 19 October 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
9 KB (587 words) - 12:00, 30 September 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
12 KB (1,323 words) - 14:55, 7 September 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
43 KB (3,675 words) - 23:48, 14 October 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
12 KB (1,289 words) - 19:20, 4 December 2023
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
15 KB (1,089 words) - 18:39, 16 October 2024
Fenspiride R03DX05 Omalizumab R03DX06 Seratrodast R03DX07 Roflumilast R03DX08 Reslizumab R03DX09 Mepolizumab R03DX10 Benralizumab R03DX11 Tezepelumab "ATC (Anatomical...
6 KB (571 words) - 10:04, 20 September 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
38 KB (3,075 words) - 05:52, 21 October 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
50 KB (6,093 words) - 20:45, 19 November 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
19 KB (2,293 words) - 11:05, 8 March 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
16 KB (1,451 words) - 18:24, 2 August 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
24 KB (2,084 words) - 05:31, 21 October 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
15 KB (1,264 words) - 06:00, 18 July 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
24 KB (2,881 words) - 19:11, 20 November 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
14 KB (1,147 words) - 07:33, 11 August 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
15 KB (1,511 words) - 05:31, 2 July 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
14 KB (1,578 words) - 23:52, 11 October 2024
Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin alfa Interleukin...
22 KB (2,581 words) - 20:03, 21 June 2024
Pexelizumab Pidilizumab Plozalizumab PRO 140† Quilizumab Ravulizumab Reslizumab Retifanlimab Rontalizumab Rovelizumab Ruplizumab Samalizumab Satralizumab...
38 KB (4,316 words) - 10:24, 26 August 2024